Evidence map›Paper›PMID 33321876›Full record

ArticlePolymers2020

Development of Porous Polyurethane Implants Manufactured via Hot-Melt Extrusion.

Ioannis Koutsamanis, Martin Spoerk, Florian Arbeiter, Simone Eder, Eva Roblegg

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. EudragitPharmaceutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ioannis KoutsamanisResearch Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Martin SpoerkResearch Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.ORCID 0000-0001-5606-3607
Florian ArbeiterInstitute of Materials Science and Testing of Polymers, Montanuniversitaet Leoben, Otto Gloeckel-Straße 2, 8700 Leoben, Austria.ORCID 0000-0003-4638-0849
Simone EderResearch Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Eva RobleggResearch Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Research Center Pharmaceutical Engineering (Austria) · ATUniversity of Graz · ATMontanuniversität Leoben · AT

Funding

Austrian Federal Ministry for Transport, Innovation and Technology (BMVIT) -Austrian Federal Ministry of Digital and Economic Affairs (BMDW) -Steirische Wirtschaftsförderungsgesellschaft -
6 · The paper itself

Abstract

Implantable drug delivery systems (IDDSs) offer good patient compliance and allow the controlled delivery of drugs over prolonged times. However, their application is limited due to the scarce material selection and the limited technological possibilities to achieve extended drug release. Porous structures are an alternative strategy that can overcome these shortcomings. The present work focuses on the development of porous IDDS based on hydrophilic (HPL) and hydrophobic (HPB) polyurethanes and chemical pore formers (PFs) manufactured by hot-melt extrusion. Different PF types and concentrations were investigated to gain a sound understanding in terms of extrudate density, porosity, compressive behavior, pore morphology and liquid uptake. Based on the rheological analyses, a stable extrusion process guaranteed porosities of up to 40% using NaHCO

Indexed as

extrusionfoampolymerpore formerscaffoldthermoplastic polyurethane

Identifiers

PMID33321876
PMCPMC7764633
OpenAlexW3112036251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.